World
Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline
In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...
April 03, 2024 | News
Abbott's Bedside Blood Test Transforms Concussion Assessment
Abbott's i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, enabling doctors to asse...
April 02, 2024 | News
Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics
Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...
March 20, 2024 | News
AstraZeneca Acquires Fusion Pharmaceuticals in a $2 Billion Upfront Deal
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-gene...
March 19, 2024 | News
Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013
Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...
March 14, 2024 | News
Glen Godresse Charts a New Course for Menarini Asia-Pacific: A Vision of Growth Through Patient-Centric Innovation
BioPharma APAC sits down with Glen Godresse, the newly appointed Chief Executive Officer of Menarini Asia-Pacific, to discuss his strategic vision for the ...
March 13, 2024 | Interview
GenScript Surges with 34.2% Revenue Growth in 2023, Sherry Shao Highlights Innovation and Team Effort
R&D Innovation to Lead the Future, Deepening Customer Value Creation Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at ...
March 13, 2024 | News
TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA
TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...
March 11, 2024 | News
Merck Opens new € 20 Million Distribution Center in Brazil
New site in Cajamar, São Paulo has 2.5 times more storage capacity than previous space in Cotia, São Paulo 13,000 square-meters space for ...
March 04, 2024 | News
Waters Launches HPLC/UPLC-MALS Integration Software for Advanced Biologic Drug Characterization
At Pittcon 2024, Waters Corporation (NYSE:WAT) unveiled the HPLC CONNECT software, a comprehensive software solution designed to facilitate seamless digita...
February 29, 2024 | News
Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development
This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...
February 23, 2024 | News
Thermo Fisher Scientific Awards Latest Oncomine Clinical Research Grants to Propel Oncology Advances
Thermo Fisher Scientific has unveiled the latest recipients of its Oncomine Clinical Research Grant, a prestigious accolade dedicated to advancing research...
February 21, 2024 | News
GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform
Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...
February 15, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
